Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
CONCLUSIONS: This score is a simple tool, easy to apply to SLE patients in daily practice. The use of the aGAPSS could change the non-pharmacologic and pharmacologic treatment in higher risk patients to improve their survival.
PMID: 33028177 [PubMed - as supplied by publisher]
Source: Lupus - Category: Rheumatology Authors: Garcia L, Velloso MS, Martire MV, Savy F, Arizpe F, Garcia N, Testi A, Pena C, Costi AC, Isnardi C, Capelusnik D, Mazza S, Curi YS, Collado V, Rodriguez MF, Scarafia S, Pisoni C, de la Torre M, Seewald A, Riva ME, Garcia M Tags: Lupus Source Type: research
More News: Antiphospholipid Syndrome | Argentina Health | Aspirin | Cardiology | Cardiovascular | Heart | Hughes Syndrome | Hydroxychloroquine | Hypertension | Laboratory Medicine | Lupus | Pregnancy | Rheumatology | Thrombosis